June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
The inhibitory effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated VEGF signaling
Author Affiliations & Notes
  • Jonggu Lee
    Fight against Angiogenesis-Related Blindness Laboratory, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea (the Republic of)
    Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Korea (the Republic of)
  • Sung Wook Park
    Fight against Angiogenesis-Related Blindness Laboratory, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea (the Republic of)
    Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Korea (the Republic of)
  • Hyoung Oh Jun
    Fight against Angiogenesis-Related Blindness Laboratory, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea (the Republic of)
  • Jin Hyoung Kim
    Fight against Angiogenesis-Related Blindness Laboratory, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea (the Republic of)
  • Byeong-Cheol Kang
    Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea (the Republic of)
    Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Korea (the Republic of)
  • Jeong Hun Kim
    Fight against Angiogenesis-Related Blindness Laboratory, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea (the Republic of)
    Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships Jonggu Lee, None; Sung Wook Park, None; Hyoung Oh Jun, None; Jin Hyoung Kim, None; Byeong-Cheol Kang, None; Jeong Hun Kim, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3159. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Jonggu Lee, Sung Wook Park, Hyoung Oh Jun, Jin Hyoung Kim, Byeong-Cheol Kang, Jeong Hun Kim; The inhibitory effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated VEGF signaling. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3159.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Pathologic retinal neovascularization is a leading cause of vision loss at all age groups. Reactive oxygen species (ROS) as well as vascular endothelial growth factor (VEGF) play important roles in pathologic retinal neovascularization. In this study, we tested the hypothesis that betaine inhibits pathologic retinal neovascularization in a mouse model of oxygen induced retinopathy (OIR) via suppression of ROS mediated VEGF signaling.

Methods: OIR was induced in C57BL/6 mice exposing 75% O2 for 5 days (postnatal day (P) 7-P12). Betaine was intravitreously injected at P14 and PBS was injected in control group (N=7/each group). At P17, neovascular tufts area in OIR retina was analyzed after staining with an anti-isolectin B4 antibody. The toxicity of betaine was evaluated by H&E stain and TUNEL stain in the retina. Cell viability was measured by WST-1 assay in human retinal microvascular endothelilal cells (HRMECs). VEGF-induced wound migration assay and proliferation assay were performed on HRMECs with treatment of betaine. The effect of betaine on VEGF-induced VEGFR-2 auto-phosphorylation and its downstream signaling were evaluated by Western blot analysis for phospho-VEGFR-2, VEGFR-2, phospho-ERK, ERK, phospho-Akt, and Akt. In HREMCs, t-butyl hydroperoxide (tBH) induced ROS production and VEGFA mRNA transcription were evaluated by DCFH-DA and quantitative PCR, respectively.

Results: Intravitreal injection of betaine effectively reduced the area of neovascular tufts in OIR retina (68.0±6.7% of the control eye, P=0.027). Even in a high concentration, betaine never induced any structural changes or toxicity in the retina or cytotoxicity in HRMECs. In vitro, betaine significantly inhibited both VEGF-induced migration and proliferation in HRMECs. In addition, betaine suppressed VEGF-induced ERK phosphorylation in HRMECs. Interestingly, betaine reduced tBH-induced ROS production. Moreover, it also attenuated tBH-induced VEGFA mRNA transcription via suppression of ROS.

Conclusions: These data suggest that betaine has an anti-angiogenic effect on pathologic retinal neovascularization via suppression of ROS mediated VEGF signaling. Betaine could be a potent anti-angiogenic agent to treat pathologic retinal neovascularization.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×